Baum Charles M

Baum Charles M is listed in filings as Director at PMV Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including 11 public disclosures. Recent filings connect the profile to PMV Pharmaceuticals, Inc. (PMVP), Acrivon Therapeutics, Inc. Common Stock (ACRV), and Poseida Therapeutics, Inc. (PSTX). The current snapshot covers public activity from Jun 18, 2024 to Jun 5, 2026. Reported amounts are shown as $50.0K to $31.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.